Episode 274: ESMO 2023 STEAP1/BiTE in CRPC shows promise
Release Date:
Kevin Kelly described a Six-transmembrane epithelial antigen of the prostate 1 (STEAP1) bispecific T cell engager showing activity in a phase 1 trial in prostate cancer.
Episode 274: ESMO 2023 STEAP1/BiTE in CRPC shows promise